Eli Lilly Announces Executive Compensation Changes

Ticker: LLY · Form: 8-K · Filed: 2024-07-10T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, officer-election, board-changes

Related Tickers: LLY

TL;DR

Lilly shakes up exec pay, new officers elected.

AI Summary

Eli Lilly & Co. announced on July 5, 2024, changes in its executive compensation arrangements. The filing details the election of new officers and adjustments to compensatory plans, impacting key personnel within the company.

Why It Matters

Changes in executive compensation can signal shifts in company strategy, performance expectations, or leadership transitions, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in executive compensation and officer elections can indicate internal shifts that may affect company strategy and performance.

Key Players & Entities

FAQ

What specific changes were made to executive compensation arrangements?

The filing indicates changes to compensatory arrangements of certain officers, but the specific details of these changes are not provided in this summary.

Who are the newly elected officers mentioned in the filing?

The filing states the election of directors and appointment of certain officers, but their names are not listed in the provided text.

What is the effective date of these changes?

The date as of change is July 10, 2024, and the report period is July 5, 2024.

What is Eli Lilly & Co.'s Standard Industrial Classification (SIC) code?

Eli Lilly & Co.'s SIC code is 2834, for Pharmaceutical Preparations.

What is the primary purpose of this 8-K filing?

This 8-K filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

From the Filing

0000059478-24-000164.txt : 20240710 0000059478-24-000164.hdr.sgml : 20240710 20240710084020 ACCESSION NUMBER: 0000059478-24-000164 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240705 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240710 DATE AS OF CHANGE: 20240710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 241108756 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 8-K 1 lly-20240705.htm 8-K lly-20240705 0000059478 false 0000059478 2024-07-05 2024-07-05 0000059478 us-gaap:CommonClassAMember 2024-07-05 2024-07-05 0000059478 lly:A718NotesDueJune12025Member 2024-07-05 2024-07-05 0000059478 lly:A1.625NotesDueJune22026Member 2024-07-05 2024-07-05 0000059478 lly:A2.125NotesDueJune32030Member 2024-07-05 2024-07-05 0000059478 lly:A625Notesdue2031Member 2024-07-05 2024-07-05 0000059478 lly:A500NotesDue2033Member 2024-07-05 2024-07-05 0000059478 lly:A6.77NotesDueJanuary12036Member 2024-07-05 2024-07-05 0000059478 lly:A1625NotesDue2043Member 2024-07-05 2024-07-05 0000059478 lly:A1.700Notesdue2049Member 2024-07-05 2024-07-05 0000059478 lly:A1125NotesDue2051Member 2024-07-05 2024-07-05 0000059478 lly:A1375NotesDue2061Member 2024-07-05 2024-07-05   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 5, 2024 ELI LILLY AND COMPANY (Exact Name of Registrant as Specified in its Charter)   Indiana   001-06351   35-0470950 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)     Lilly Corporate Center Indianapolis, Indiana 46285 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: ( 317 ) 276-2000 Not Applicable (Former Name or Former Address, if Changed Since Last Report.)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2.): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock (no par value) LLY New York Stock Exchange 7 1/8% Notes due 2025 LLY25 New York Stock Exchange 1.625% Notes due 2026 LLY26 New York Stock Exchange 2.125% Notes due 2030 LLY30 New York Stock Exchange 0.625% Notes due 2031 LLY31 New York Stock Exchange 0.500% Notes due 2033 LLY33 New York Stock Exchange 6.77% Notes due 2036 LLY36 New York Stock Exchange 1.625% Notes due 2043 LLY43 New York Stock Exchange 1.700% Notes due 2049 LLY49A New York Stock Exchange 1.125% Notes due 2051 LLY51 New York Stock Exchange 1.375% Notes due

View on Read The Filing